Objectif The European Pharma industry is a major contributor to EU well-being, both in public health and economic (sales >200 billion €/year) terms. To maintain global leadership, it must respond to challenges from low-cost producers e.g. China by bringing new drug molecules to market in a streamlined, cost-effective manner. This strategy is underscored by recent initiatives of European regulators to expedite the approval of “breakthrough drugs” so patients can gain earlier access to life-saving drugs. To realise these goals, scientists with an integral understanding of drug development and regulatory approval processes are urgently needed. PEARRL will train 15 Early Stage Researchers (ESR) who can develop new bio-enabling formulations (“better drugs”), biorelevant and in silico methods to predict formulation performance in vivo (“streamlined development”) and serve as communication bridgers between research and regulatory science (“accelerated approval”), thus bringing Pharma and regulatory objectives to fruition. PEARRL brings a multi-sectorial team, comprising key European regulatory authorities, academic leaders in bio-enabling formulations and biopharmaceutics tools, and an array of Pharma companies with a wealth of combined experience in bringing molecules to market, together for the first time to deliver a unique research and training programme. Key PEARRL elements are individual research projects with synergistic output; exposure of all ESR to academia, industry and regulatory in secondments; and ongoing innovative learning via Online Portals, Science Slams and Boot Camps. Key PEARRL impacts will be availability of excellent pharmaceutical researchers; streamlined drug development with a higher success rate for the industrial partners; enriched academic research through cooperation with industry and regulatory; earlier availability of breakthrough medicines to patients; a competitive pharma industry in Europe and contributions to European public health interests. Champ scientifique medical and health scienceshealth sciencespublic healthmedical and health sciencesbasic medicinepharmacology and pharmacysocial scienceseconomics and businessbusiness and managementcommerce Programme(s) H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions Main Programme H2020-EU.1.3.1. - Fostering new skills by means of excellent initial training of researchers Thème(s) MSCA-ITN-2015-ETN - Marie Skłodowska-Curie Innovative Training Networks (ITN-ETN) Appel à propositions H2020-MSCA-ITN-2015 Voir d’autres projets de cet appel Régime de financement MSCA-ITN - Marie Skłodowska-Curie Innovative Training Networks (ITN) Coordinateur UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK Contribution nette de l'UE € 531 349,20 Adresse WESTERN ROAD T12 YN60 Cork Irlande Voir sur la carte Région Ireland Southern South-East Type d’activité Higher or Secondary Education Establishments Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 531 349,20 Participants (9) Trier par ordre alphabétique Trier par contribution nette de l'UE Tout développer Tout réduire JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN Allemagne Contribution nette de l'UE € 747 649,44 Adresse THEODOR W ADORNO PLATZ 1 60323 Frankfurt Am Main Voir sur la carte Région Hessen Darmstadt Frankfurt am Main, Kreisfreie Stadt Type d’activité Higher or Secondary Education Establishments Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 747 649,44 ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON Grèce Contribution nette de l'UE € 484 773,84 Adresse 6 CHRISTOU LADA STR 10561 Athina Voir sur la carte Région Αττική Aττική Κεντρικός Τομέας Αθηνών Type d’activité Higher or Secondary Education Establishments Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 484 773,84 UNIVERSITY OF BATH Royaume-Uni Contribution nette de l'UE € 546 575,76 Adresse CLAVERTON DOWN BA2 7AY Bath Voir sur la carte Région South West (England) Gloucestershire, Wiltshire and Bristol/Bath area Bath and North East Somerset, North Somerset and South Gloucestershire Type d’activité Higher or Secondary Education Establishments Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 546 575,76 FACHHOCHSCHULE NORDWESTSCHWEIZ FHNW Suisse Contribution nette de l'UE € 530 453,52 Adresse BAHNHOFSTRASSE 6 5210 Windisch Voir sur la carte Région Schweiz/Suisse/Svizzera Nordwestschweiz Aargau Type d’activité Higher or Secondary Education Establishments Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 530 453,52 H. LUNDBECK AS Participation terminée Danemark Contribution nette de l'UE € 0,00 Adresse OTTILIAVEJ 7-9 2500 Valby Voir sur la carte Région Danmark Hovedstaden Byen København Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total Aucune donnée MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN Allemagne Contribution nette de l'UE € 249 216,48 Adresse FRANKFURTER STRASSE 250 64293 Darmstadt Voir sur la carte Région Hessen Darmstadt Darmstadt, Kreisfreie Stadt Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 249 216,48 PHARMATEN ANONYMOS VIOMICHANIKI KAI EMPORIKI ETAIREIA PHARMAKEFTIKON KAI KALLYNTIKON PROIONTON Grèce Contribution nette de l'UE € 242 386,92 Adresse DERVENAKION STREET 6 15351 PALLINI Voir sur la carte Région Αττική Aττική Ανατολική Αττική Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 242 386,92 PION INC.(UK) LTD Royaume-Uni Contribution nette de l'UE € 273 287,88 Adresse RIVERSIDE FOREST ROW BUSINESS PARK RH18 5DW FOREST ROW Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Région South East (England) Surrey, East and West Sussex East Sussex CC Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 273 287,88 JANSSEN PHARMACEUTICA NV Belgique Contribution nette de l'UE € 250 560,00 Adresse TURNHOUTSEWEG 30 2340 Beerse Voir sur la carte Région Vlaams Gewest Prov. Antwerpen Arr. Turnhout Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 250 560,00